Clinical and Life Sciences · 1 October 2026 to 1 October 2026 · 1 headlines · STAT
STAT Plus: A journey to witness China’s biotech boom up close
A STAT Plus report describes a journey undertaken to observe China's biotech boom firsthand.
As it ran
1 October 2026
More from US healthcare
- STAT Plus: A major insurer on how it may replicate Medicare’s chronic-care experiment 1 October 2026
- Pennsylvania Records a Fifth Measles Death as U.S. Endures Its Worst Year Since 1991 1 October 2026
- UniQure's Huntington's gene therapy trial 1 October 2026
- Data privacy concerns could hold patients back from using AI 1 October 2026
- Epic Fail: Robots Don't Improve Joint Replacement Outcomes in Big U.K. Studies 1 October 2026
- I studied GLP-1 use in children. The results are reassuring 1 October 2026
- 'Lean' MASLD May Sound Better, but Study Suggests Otherwise 1 October 2026
- Merck discontinues antibiotic Recarbrio in US 1 October 2026